47 /100
MEDIUM RISK
Score updated Jul 14, 2026

STXS — Stereotaxis, Inc. Dilution Risk Tracker

Track STXS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STXS — Get alerts when the score changes →

As of July 14, 2026, Stereotaxis, Inc. (STXS) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Stereotaxis, Inc. has a market capitalization of $193.52M, 97.74M shares outstanding, 116 institutional holders tracked. Key dilution vectors include 36.92M outstanding warrants, approximately 17 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
35
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
39%
📜 Warrant Exercise 60%
• Massive warrant overhang: 38% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split 30%
• 50-day avg $1.90 approaching $1 threshold
🔔 Track STXS — Get forecast alerts →

💹 Market Data

Market Cap$193.52M
Shares Outstanding97.74M
Float69.08M
Cash$14.62M
Debt$293.4K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.3% shares (2026Q1 vs prior)
116 institutional holders · 48.69M shares
#1 DAFNA Capital Management LLC 13.68M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 6.00M shares
#3 Lagoda Investment Management, L.P. 4.35M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.26M
Days to Cover6.1
% of Float6.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Jan 02, 2026
4 INSIDER TRANSACTION Jan 02, 2026
4 INSIDER TRANSACTION Jan 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for STXS Shareholders

Stereotaxis, Inc. (STXS) has a DilutionScore of 47/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 36.9M outstanding warrants for STXS. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: STXS has approximately 17 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for STXS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for STXS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track STXS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STXS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for STXS
📊 STXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 STXS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.